glp-1 agonist alzheimer's drugs show promise in treatment despite trial setback | Zain Khalpey, MD, PhD, FACS posted on the topic glp-1 new hope Receptor Agonists:

A 41-women eye cream study showed GHK-Cu outperformed both placebo and vitamin K on line reduction and dermal density

Both are associated with systemic inflammation and a higher risk of heart disease

They did also talk about One study assessed the mutagenicity and teratogenicity of the compound, basically looking at, do any mutations occur by injecting, or are there any effects of like fetal development? That one study did not prove that there was any kind of that ill effect occurring from BPC-157, but that doesnt mean its safe

10.1002/adfm.201907954 86 ZhouL.WangH.LiY

Restoration of p53 function leads to tumour regression in vivo

[13] [15] Common side effects include local reactions at the injection site, such as pain, swelling, or erythema